Concurrent Chemotherapy of Malignant Glioma in Rats by Using Multidrug-Loaded Biodegradable Nanofibrous Membranes

Current approaches to enhance CNS delivery of drugs across the brain barriers

(2014) Cui-Tao Lu et al.   International Journal of Nanomedicine

In vivo and ex vivo assessment of the blood brain barrier integrity in different glioblastoma animal models

(2014) Cindy Leten et al.   JOURNAL OF NEURO-ONCOLOGY

Sustainable release of carmustine from biodegradable poly[(d,l)-lactide-co-glycolide] nanofibrous membranes in the cerebral cavity:in vitroandin vivostudies

(2013) Yuan-Yun Tseng et al.   Expert Opinion on Drug Delivery

Role of nanobiotechnology in the personalized management of glioblastoma multiforme

(2011) Kewal K Jain   Nanomedicine

Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier

(2011) Hirenkumar K. Makadia et al.   Polymers

Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma

(2010) S. Kunwar et al.   NEURO-ONCOLOGY

Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy

(2009) Mary Lou Affronti et al.   CANCER

The potential for nanoparticle-based drug delivery to the brain: overcoming the blood–brain barrier

(2009) Eugen Barbu et al.   Expert Opinion on Drug Delivery

Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma

(2009) Henry S. Friedman et al.   JOURNAL OF CLINICAL ONCOLOGY

EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME

(2009) et al.   NEUROSURGERY

Use of Gliadel (BCNU) Wafer in the Surgical Treatment of Malignant Glioma: A 10-Year Institutional Experience

(2008) Frank J. Attenello et al.   ANNALS OF SURGICAL ONCOLOGY

Polymeric nanoparticles for the drug delivery to the central nervous system

(2008) Giovanni Tosi et al.   Expert Opinion on Drug Delivery

Drug cocktails for effective treatment of glioblastoma multiforme

(2008) Waldemar Debinski   Expert Review of Neurotherapeutics

Experience with irinotecan for the treatment of malignant glioma

(2008) James J. Vredenburgh et al.   NEURO-ONCOLOGY